Researcher profile

Marlena S. Bannick

Marlena S. Bannick contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Methodology Applications

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author

2works

0followers

2topics

3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2

COVID-19 vaccines are highly efficacious at preventing symptomatic infection, severe disease, and death. Most of the evidence that COVID-19 vaccines also reduce transmission of SARS-CoV-2 is based on retrospective, observational studies. Specifically, an increasing number of studies are evaluating vaccine efficacy against the secondary attack rate of SARS-CoV-2 using data available in existing healthcare databases or contact tracing databases. Since these types of databases were designed for clinical diagnosis or management of COVID-19, they are limited in their ability to provide accurate information on infection, infection timing, and transmission events. In this manuscript, we highlight challenges with using existing databases to identify transmission units and confirm potential SARS-CoV-2 transmission events. We discuss the impact of common diagnostic testing strategies including event-prompted and infrequent testing and illustrate their potential biases in estimating vaccine efficacy against the secondary attack rate of SARS-CoV-2. We articulate the need for prospective observational studies of vaccine efficacy against the SARS-CoV-2 SAR, and we provide design and reporting considerations for studies using retrospective databases.

preprint2021arXiv

Statistical Considerations for Cross-Sectional HIV Incidence Estimation Based on Recency Test

Longitudinal cohorts to determine the incidence of HIV infection are logistically challenging, so researchers have sought alternative strategies. Recency test methods use biomarker profiles of HIV-infected subjects in a cross-sectional sample to infer whether they are "recently" infected and to estimate incidence in the population. Two main estimators have been used in practice: one that assumes a recency test is perfectly specific, and another that allows for false-recent results. To date, these commonly used estimators have not been rigorously studied with respect to their assumptions and statistical properties. In this paper, we present a theoretical framework with which to understand these estimators and interrogate their assumptions, and perform a simulation study to assess the performance of these estimators under realistic HIV epidemiological dynamics. We conclude with recommendations for the use of these estimators in practice and a discussion of future methodological developments to improve HIV incidence estimation via recency test.

Institution

Affiliation not imported yet

This author record came from a source that does not expose affiliation metadata. Once the author claims the profile or we enrich the record from another provider, this section will link to the concrete institution.

Topic footprint